Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-02 Sale |
2025-01-03 5:03 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
8,510 | $0.5619 | $4,782 | 204,094 (Direct) |
View |
| 2024-09-05 Sale |
2024-09-05 7:49 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
2,525 | $0.566 | $1,429 | 92,684 (Direct) |
View |
| 2024-01-05 Sale(A) |
2024-02-16 4:32 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
2,412 | $2.91 | $7,019 | 80,256 (Direct) |
View |
| 2023-01-05 Sale |
2024-01-08 4:36 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
2,412 | $2.91 | $7,019 | 80,256 (Direct) |
View |
| 2022-06-23 Sale |
2022-06-24 7:25 pm |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
2,614 | $2.69 | $7,032 | 57,695 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-04 4:30 pm |
N/A 2035-03-02 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
146,408 | $0 | 146,408 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-03 5:03 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
36,667 | $0 | 204,094 (Direct) |
View |
| 2024-11-18 Option Award |
2025-01-03 5:03 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
9,920 | $0.55 | 204,094 (Direct) |
View |
| 2024-10-01 Option Award |
2024-10-03 7:10 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
220,000 | $0 | 220,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-09-05 7:49 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
4,953 | $1.34 | 92,684 (Direct) |
View |
| 2024-09-03 Option Award |
2024-09-05 7:49 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
10,000 | $0 | 92,684 (Direct) |
View |
| 2024-02-14 Option Award |
2024-02-16 4:54 pm |
N/A 2034-02-13 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
220,000 | $0 | 220,000 (Direct) |
View |
| 2023-11-20 Option Award(A) |
2024-02-16 4:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
3,397 | $1.34 | 80,256 (Direct) |
View |
| 2023-05-18 Option Award(A) |
2024-02-16 4:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
809 | $2.41 | 80,256 (Direct) |
View |
| 2024-01-04 Option Award(A) |
2024-02-16 4:32 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER |
10,000 | $0 | 80,256 (Direct) |
View |
| 2023-11-20 Option Award |
2024-01-08 4:36 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
3,397 | $1.34 | 80,256 (Direct) |
View |
| 2023-05-18 Option Award |
2024-01-08 4:36 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
809 | $2.41 | 80,256 (Direct) |
View |
| 2023-01-04 Option Award |
2024-01-08 4:36 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
10,000 | $0 | 80,256 (Direct) |
View |
| 2023-03-24 Exercise |
2023-03-27 4:57 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
6,410 | $1.35 | 68,462 (Direct) |
View |
| 2023-03-24 Exercise |
2023-03-27 4:57 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer |
6,410 | $0 | 68,462 (Direct) |
View |
| 2022-11-18 Option Award |
2023-01-23 5:26 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
657 | $2.74 | 212,052 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 5:26 pm |
N/A 2033-01-18 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
150,000 | $0 | 212,052 (Direct) |
View |
| 2022-10-28 Exercise |
2022-10-31 8:17 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,700 | $1.35 | 67,805 (Direct) |
View |
| 2022-10-28 Exercise |
2022-10-31 8:17 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,700 | $0 | 67,805 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-24 7:25 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
10,000 | $0 | 57,695 (Direct) |
View |
| 2022-05-18 Option Award |
2022-06-10 5:53 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
243 | $7.06 | 60,419 (Direct) |
View |
| 2022-06-08 Exercise |
2022-06-10 5:53 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
2,500 | $1.35 | 60,419 (Direct) |
View |
| 2022-06-08 Exercise |
2022-06-10 5:53 pm |
N/A 2028-12-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
2,500 | $0 | 60,419 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-18 7:38 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,152 | $1.19 | 47,566 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-18 7:38 pm |
N/A 2027-06-18 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
3,152 | $0 | 47,566 (Direct) |
View |
| 2021-11-18 Option Award |
2022-01-20 5:24 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
96 | $12.51 | 144,414 (Direct) |
View |
| 2022-01-18 Option Award |
2022-01-20 5:24 pm |
N/A 2032-01-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Executive VP, Research |
100,000 | $0 | 144,414 (Direct) |
View |
| 2021-06-08 Exercise(A) |
2021-06-10 6:41 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
3,152 | $1.04 | 44,318 (Direct) |
View |
| 2021-05-18 Option Award(A) |
2021-06-10 6:41 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
185 | $14.45 | 44,318 (Direct) |
View |
| 2021-06-08 Exercise(A) |
2021-06-10 6:41 pm |
N/A 2026-08-30 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
3,152 | $0 | 44,318 (Direct) |
View |
| 2021-06-08 Exercise |
2021-06-09 5:39 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
3,152 | $1.04 | 44,133 (Direct) |
View |
| 2021-06-08 Exercise |
2021-06-09 5:39 pm |
N/A 2026-08-30 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
3,152 | $0 | 44,133 (Direct) |
View |
| 2021-02-18 Option Award |
2021-02-22 5:31 pm |
N/A 2031-02-17 |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
20,000 | $0 | 20,000 (Direct) |
View |
Ownership |
2020-09-17 8:31 pm |
N/A N/A |
Athira Pharma Inc. | ATHA | CHURCH KEVIN Vice President of Discovery |
0 | $0 | 129,880 (Direct) |
View |